A team led by researchers at Baylor College of Medicine and Washington University School of Medicine has shed light on the ...

Persistent heartburn, often dismissed, could signal esophageal cancer, a condition affecting the food passage. Early detection is crucial due to late-stage symptom onset. Chronic heartburn, linked to ...

While most episodes of vomiting don't lead to Boerhaave syndrome, it is a rare possibility, and vomiting can cause other types of damage to your esophagus.

Esophageal adenocarcinoma (EAC), one of two major forms of esophageal cancer, is the sixth most deadly cancer worldwide for ...

BE is the only known precursor to esophageal cancer. The condition is caused by prolonged exposure of the esophagus to ...

This is a good way to learn from people with experience in managing this part of the treatment. For more information, see Colostomy Guide and Ileostomy Guide. Surgery for colon cancer spread If the ...

Some of the most harmful genetic changes in cancer are also the hardest to see. These structural alterations, deep within a tumor's DNA, can fuel aggressive growth and evade standard testing ...

Cytoreductive surgery and advances in systemic therapy have improved the prognosis of primary advanced ovarian cancer and the therapeutic aim has shifted from a palliative situation to cure or at ...

A team from the Institute of Cancer Research, London, and Queen Mary University of London have designed a new technology that uses evolutionary biology to measure and predict how cancer cells will ...

A group of Ugandan health workers is set to benefit from a specialized training program on esophageal cancer management through a new partnership between the Uganda Cancer Institute and United ...

Cancer plasticity allows tumor cells to change their identity, evade therapies, and adapt to environmental pressures, contributing to treatment resistance and metastasis. New research is targeting ...

World-first "undruggable" cancer treatment enters human trial By Bronwyn Thompson June 13, 2025 Novel cancer drug PMR-116 will be put to the test in a world first trial in 2025 ...